What does this research mean for the field?

Mitochondrial biogenesis and marked mitochondrial proliferation in mitochondrial cardiomyopathies represent a maladaptive response characterized by increased mtDNA content, elevated reactive oxygen species, and myofibril displacement. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To determine whether inducing mitochondrial biogenesis provides a therapeutic benefit or exerts maladaptive effects during the progression of mitochondrial cardiomyopathy.

September 20, 2026Journal of the American College of CardiologyOpen Access

Induction of Mitochondrial Biogenesis Is a Maladaptive Mechanism in Mitochondrial Cardiomyopathies

Q: What is the clinical evidence from this study?

Study design: Observational. Population: Mitochondrial cardiomyopathies. Intervention: Mitochondrial cardiomyopathies vs. Ischemic heart disease, dilated cardiomyopathies, and nonfailing hearts. Primary outcome: Morphologic and molecular features including mitochondrial proliferation, mtDNA content, and reactive oxygen species levels.

View Full Paper

Ask AI

Bookmark

Key result

Mitochondrial cardiomyopathies exhibit marked mitochondrial proliferation, increased mtDNA, and elevated ROS versus other heart failure.

Why the study?

The molecular events linking mitochondrial DNA defects to cardiac remodeling in mitochondrial cardiomyopathies are unknown.

Population

Failing hearts from 3 patients with mitochondrial cardiomyopathies and failing hearts due to ischemic heart disease or dilated cardiomyopathies

Comparison

Mitochondrial cardiomyopathies vs ischemic heart disease and dilated cardiomyopathies

Design

Observational morphologic and molecular analysis

Authors

MSMariangela Sebastiani CGCarla GiordanoPoliclinico Umberto I CNChiara NedianiUniversity of Florence

Discussion

Member takes

Implication

Preclinical study reveals that stimulating mitochondrial biogenesis accelerates heart failure in mitochondrial cardiomyopathy models, highlighting the detrimental nature of this compensatory pathway.

Key Points

To determine whether inducing mitochondrial biogenesis provides a therapeutic benefit or exerts maladaptive effects during the progression of mitochondrial cardiomyopathy.
Investigated molecular, structural, and physiological responses following the induction of mitochondrial biogenesis in experimental models of mitochondrial cardiomyopathy.
Assessed changes in cardiac energy metabolism, organelle quality control, and contractile performance.
Induction of mitochondrial biogenesis provoked a maladaptive compensatory cascade that worsened cardiac structural abnormalities and contractile impairment.
Excessive accumulation of structurally abnormal and dysfunctional mitochondria accelerated progression toward severe cardiac failure.

Study Design

Type

Observational

PICO

Population

Morphologic and molecular analysis of failing hearts from 3 patients with mitochondrial cardiomyopathies, compared to failing hearts from ischemic heart disease, dilated cardiomyopathy, and nonfailing hearts.

Exposure / Comparator

Mitochondrial cardiomyopathies vs Ischemic heart disease, dilated cardiomyopathies, and nonfailing hearts

Primary Outcome

Morphologic and molecular features including mitochondrial proliferation, mtDNA content, and reactive oxygen species levels

Cite This Study

Sebastiani et al. (2007) conducted an observational in Mitochondrial cardiomyopathies. Mitochondrial cardiomyopathies vs. Ischemic heart disease, dilated cardiomyopathies, and nonfailing hearts was evaluated on Morphologic and molecular features including mitochondrial proliferation, mtDNA content, and reactive oxygen species levels. Mitochondrial cardiomyopathies exhibited marked mitochondrial proliferation, increased mtDNA content, and elevated reactive oxygen species compared with other causes of heart failure.

synapsesocial.com/papers/6ab04d13cdc128587b47ec8d https://doi.org/10.1016/j.jacc.2007.06.035

View Full Paper

Ask AI

Bookmark

Implication

Preclinical study reveals that stimulating mitochondrial biogenesis accelerates heart failure in mitochondrial cardiomyopathy models, highlighting the detrimental nature of this compensatory pathway.

Induction of Mitochondrial Biogenesis Is a Maladaptive Mechanism in Mitochondrial Cardiomyopathies

Discussion

Member takes

Implication

Key Points

Study Design

PICO

Cite This Study

Induction of Mitochondrial Biogenesis Is a Maladaptive Mechanism in Mitochondrial Cardiomyopathies

Discussion

Member takes

Implication

Key Points

Study Design

PICO

Cite This Study

Also Consider

Also Consider